key: cord-0708833-ceeln2oh authors: Hassan, Sk. Sarif; Choudhury, Pabitra Pal; Roy, Bidyut; Jana, Siddhartha Sankar title: Missense mutations in SARS-CoV2 genomes from Indian patients date: 2020-08-19 journal: Genomics DOI: 10.1016/j.ygeno.2020.08.021 sha: bc9633d070bd325d40fff93613c074d5ff0c5697 doc_id: 708833 cord_uid: ceeln2oh Abstract The genetic diversity of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) in several countries sums up a large fraction of its worldwide genetic diversity. In this present study, variations in terms of missense mutations among the SARS-CoV2 genomes from 128 Indian patients, as of May 2020, are accounted and thereby some key findings with some hypotheses were made. These mutations across various genes of these genomes show wide genetic variations in sequence and rapid evolution of SARS-CoV2 virus. The presence of unique mutations in the studied SARS-CoV2 genomes has led to their attenuation. Few Genes such as ORF6, ORF10 are free from any mutations in the Indian context of 339 genomes observed as of 14th July 2020. Further, E protein contains only one mutation. This may suggest that designing a therapeutic approach against ORF6, ORF10 and E genes may have a beneficial effect in controlling COVID-19 pandemic especially in India. The pandemic of COVID-19, caused by the RNA coronavirus SARS-CoV2 has spread over 200 countries and infected millions of people worldwide [1, 2] . The rate of mutation of RNA viruses is much higher than that of their hosts [3, 4] . The rapid spread of COVID-19 across various countries opens an intriguing question whether the variations in genome sequences of the novel coronavirus are contributing to the variation of infection and mortality rate [5, 6] . Having this question in mind, with the reference to the Wuhan based genome NC_045512, missense mutations were identified in the SARS-CoV2 genomes of the COVID-19 affected Indian patients. This study of mutations in the SARS-CoV2 genomes of 128 COVID-19 affected Indian patients has been carried out. Various mutations over the proteins of SARS-CoV2 genomes are presented in the articles [7, 8, 9, 10, 11, 12, 13] . A comprehensive list of patients with other associated details are presented in the Table 1 . It is to be noted that most of these 128 patients were infected in Europe and USA and came back to India. Some of them were infected from neighbour Indian patients. Mutations of an amino acid 1 A to an amino acid 2 A is denoted by 12 denotes location in the reference amino acid sequence. The third column of the Table 2 Table 2 , 3, 4 and 5 as follows:  Maximum number of missense mutations were found to be 11 which occurred in two genomes MT451890 (Ahmedabad-Gujrat) and MT509510(Una-Himachal Pradesh). Note that the only common missense mutations among these 11 mutations is P(4715)L. Therefore, we propose that these two patients (one from Gujrat and another from Himachal Pradesh, located 1300 KM apart) were infected by two different strains of the virus.  From Una, MT509507 genome has ten different missense mutations that are significantly different from others, which is depicted in the Several missense mutations over these 128 SARS-CoV2 genomes from Indian patients from Gandhinagar C(857)C, F(924)F, P(4715) S(1) There are several missense mutations in the different genes across the genomes of SARS-CoV2 from Indian patients. Some of the conclusive inferences as well as hypotheses are drawn A review of coronavirus disease-2019 (covid-19) Whole genome and phylogenetic analysis of two sars-cov-2 strains isolated in italy in january and february 2020: additional clues on multiple introductions and further circulation in europe Origin and evolution of pathogenic coronaviruses Emerging sars-cov-2 mutation hot spots include a novel rna-dependent-rna polymerase variant Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in wuhan, china, Microbes and infection Genetic diversity and evolution of sars-cov-2, Infection Molecular conservation and differential mutation on orf3a gene in indian sars-cov2 genomes Sars-cov2 envelope protein: non-synonymous mutations and its consequences Genetic diversity and genomic epidemiology of sars-cov-2 in morocco Genetic variations and drug repurposing provides key insights into the disruption of the sars Identification of novel missense mutations in a large number of recent sars-cov-2 genome sequences Sars-cov2 (covid-19) structural/evolution dynamicome: Insights into functional evolution and human genomics Emergence of genomic diversity and recurrent mutations in sars-cov-2, Infection The authors do not have any conflicts of interest to declare.